Clinical Trial: A Pilot Study, Evaluating the Efficacy of Regulatory T-Cell Suppression by Ontak in Metastatic Pancreatic Cancer

Share this article:

A Pilot Study, Evaluating the Efficacy of Regulatory T-Cell Suppression by Ontak in Metastatic Pancreatic Cancer


Sponsor and Collaborators
Loyola University
Riveria Country Club Organization
Eisai Inc.

Contact
Camille Deluhery
708-327-1240
cdeluhery@lumc.edu
Kathy Czaplicki
708-327-3222
KCZAPLI@lumc.edu

Principal Investigator

Margo Shoup, MD
Loyola University

Clinical Trials.gov Identifier

NCT00726037
Share this article:
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters


What is this?

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs

More in Pancreatic Cancer Clinical Trials

Clinical Trial: BrUOG 278: FOLFOX-A For Pancreatic Cancer A Brown University Oncology ...

Clinical trial focusing on BrUOG 278. BrUOG 278: FOLFOX-A For Pancreatic Cancer A Brown University Oncology Research Group Study

Clinical Trial: Mirtazapine Plus Gemcitabine Versus Gemcitabine in Metastasis Pancreatic Cancer

Clinical trial focusing on mirtazapine and gemcitabine. Mirtazapine Plus Gemcitabine Versus Gemcitabine in Metastasis Pancreatic Cancer

Clinical Trial: Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX ...

Clinical trial focusing on sterotactic radion therapy and Folfirinox. Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic Cancer